Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18785,900,1.26 [1.14-1.40],6.927344369503911e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,18040,290,1.60 [1.34-1.91],2.194621361740308e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21299,178,1.48 [1.18-1.85],0.0006088080613427
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13195,1079,1.43 [1.30-1.58],6.599318834146679e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21254,133,1.49 [1.15-1.93],0.0024442351665255
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18832,95,1.95 [1.44-2.64],1.4136099501661406e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22699,132,1.50 [1.16-1.95],0.0020374510278242
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22686,89,1.19 [0.87-1.64],0.280458970468848
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18344,71,1.92 [1.35-2.74],0.0003000376134711
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21550,129,1.60 [1.24-2.08],0.0003671290192892
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21507,86,1.99 [1.45-2.72],1.735982672561047e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22806,66,0.98 [0.68-1.42],0.9314639318525144
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22836,67,1.36 [0.94-1.96],0.0977011211226277
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22833,64,1.38 [0.95-2.00],0.0950579023702787
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,22343,60,1.28 [0.87-1.89],0.2090324575329238
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21239,433,1.17 [1.01-1.35],0.0355530804002791
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,20940,134,1.32 [1.02-1.71],0.0339977387647075
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21124,318,1.13 [0.95-1.33],0.1710791470594567
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16418,99,1.06 [0.79-1.43],0.708908046160908
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16382,63,0.91 [0.62-1.32],0.6107719102997543
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16719,400,1.01 [0.87-1.18],0.8565928659839978
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16731,412,1.02 [0.88-1.18],0.8167567103825271
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9402,379,1.03 [0.88-1.20],0.747369291324641
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7503,207,0.90 [0.72-1.12],0.3599688122422082
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16377,58,1.04 [0.70-1.55],0.8310826879133664
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19486,756,1.50 [1.34-1.67],1.1666311112988644e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21316,461,1.01 [0.88-1.16],0.8861298505381859
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22304,154,1.05 [0.82-1.33],0.7189050678851943
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22889,146,1.08 [0.85-1.39],0.522731141944322
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,22572,87,0.80 [0.58-1.10],0.1769084254362108
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22899,94,1.14 [0.84-1.55],0.4111977460301189
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Stomach,22952,69,1.00 [0.70-1.43],0.9999495176626388
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,22718,293,0.86 [0.72-1.02],0.0880219160739352
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22934,99,0.81 [0.60-1.09],0.1640668865255531
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22939,84,1.30 [0.94-1.80],0.1157336993873772
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22852,58,0.94 [0.64-1.40],0.767928703207257
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",22855,57,0.92 [0.62-1.37],0.6905788343811845
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,22799,148,0.81 [0.64-1.04],0.0994421560291643
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,22933,64,0.86 [0.59-1.25],0.4290478110513898
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,22812,175,0.95 [0.75-1.19],0.6414222336945373
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of breast,11999,44,1.22 [0.78-1.90],0.3923790784478682
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,11854,304,1.03 [0.87-1.22],0.7583695754349457
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21382,192,1.40 [1.13-1.74],0.0021152258304909
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,20849,345,1.60 [1.36-1.88],1.0772855095057325e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,20849,345,1.60 [1.36-1.88],1.0772855095057325e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18306,554,1.29 [1.13-1.47],0.0001447864954131
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22338,59,1.71 [1.16-2.53],0.0068269671683859
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22610,62,1.22 [0.83-1.78],0.3148667065683374
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16582,1638,1.15 [1.07-1.25],0.0004052910618811
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21221,637,1.16 [1.03-1.31],0.0139451467893104
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20159,152,2.58 [2.03-3.28],9.271406834888803e-15
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21356,164,1.44 [1.14-1.82],0.0020528419720097
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20147,140,2.40 [1.87-3.08],5.928586885929628e-12
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,20775,768,1.70 [1.52-1.91],7.748262480251166e-20
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,20749,742,1.70 [1.51-1.91],3.2712963220157337e-19
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21087,185,0.96 [0.75-1.22],0.728307481299914
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21086,184,0.96 [0.75-1.22],0.7288840976691273
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16401,1457,1.11 [1.02-1.21],0.0141067332644861
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15132,188,1.37 [1.10-1.70],0.0049133820589939
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16293,1349,1.11 [1.01-1.21],0.0234277249658753
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15002,58,1.38 [0.93-2.03],0.1110451825872115
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15036,92,1.99 [1.46-2.72],1.2299039425261772e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,18776,535,1.22 [1.07-1.40],0.0030271320449853
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18398,157,0.97 [0.76-1.24],0.8048740630538866
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22585,111,1.01 [0.76-1.36],0.9251895752791098
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22645,83,1.09 [0.78-1.53],0.6177165614317142
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21408,33,1.51 [0.90-2.52],0.1190482288491627
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",22874,33,1.56 [0.93-2.61],0.0931389197950359
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18274,33,1.55 [0.92-2.62],0.1019921037288303
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Alcohol dependence,21417,42,1.08 [0.68-1.71],0.7602667123973366
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,21340,48,0.84 [0.55-1.30],0.4361542570005722
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18276,35,1.32 [0.80-2.18],0.2809288242322132
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18500,259,1.53 [1.27-1.84],8.945587634585618e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Depression,21493,228,1.51 [1.24-1.85],4.092934720399632e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,18141,196,1.52 [1.23-1.89],0.0001194027932433
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18350,109,1.06 [0.79-1.41],0.6969263885295228
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Other anxiety disorders,21553,63,0.88 [0.60-1.29],0.516923695045256
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,18647,1479,1.20 [1.10-1.30],1.4413498512392444e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16315,102,0.96 [0.71-1.29],0.7766649260606301
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22861,80,0.93 [0.67-1.30],0.6764723399721322
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21629,458,1.28 [1.11-1.48],0.0005539617204723
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,21299,128,1.87 [1.44-2.42],2.4841707580427674e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,21227,56,1.26 [0.85-1.89],0.2535781836431197
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22723,50,1.23 [0.81-1.88],0.3276066951897375
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21780,117,1.06 [0.80-1.40],0.6748663552074671
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,21327,156,0.98 [0.77-1.25],0.8866514305363369
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,22425,117,1.09 [0.83-1.44],0.5222417044735936
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",21757,709,1.11 [0.99-1.24],0.0783043706822063
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21151,103,0.91 [0.67-1.22],0.5183078562114682
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21481,433,1.20 [1.04-1.39],0.0119503079562925
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22566,79,1.86 [1.33-2.59],0.0002558831434029
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,22547,60,2.14 [1.46-3.12],8.36076705789476e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,22400,119,1.20 [0.91-1.58],0.1898587098525616
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22097,415,1.16 [1.00-1.34],0.0516805784811824
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21933,251,1.12 [0.92-1.35],0.2516756197543369
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21742,60,1.20 [0.81-1.76],0.3594006420773417
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21816,134,0.96 [0.74-1.25],0.7713407016957576
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21785,103,1.26 [0.94-1.70],0.1165993288232861
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17559,255,1.41 [1.17-1.71],0.0003044432934247
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17910,606,1.15 [1.02-1.30],0.0263251205856232
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21556,297,1.34 [1.13-1.60],0.0008866875118172
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22531,81,2.22 [1.61-3.07],1.4332618216018582e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2591,81,2.09 [1.50-2.90],1.1078011649262948e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20021,81,2.27 [1.64-3.15],8.880794175665348e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,21978,133,0.93 [0.72-1.21],0.5960622880769456
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,21917,72,0.81 [0.57-1.15],0.2448349028533539
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22041,78,1.10 [0.78-1.55],0.5789526102123275
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22273,96,1.00 [0.74-1.36],0.9852374133815136
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,22861,141,1.21 [0.94-1.55],0.1447995970783602
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,21739,110,1.17 [0.88-1.56],0.2701851914452851
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,14151,4543,1.16 [1.09-1.23],5.80150287317963e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22006,96,1.26 [0.92-1.71],0.1459808249903592
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14988,3181,1.16 [1.08-1.23],8.558266054359625e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,15030,3223,1.17 [1.10-1.25],1.153189746731133e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11912,105,2.28 [1.70-3.05],4.268018402184013e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20101,1814,1.17 [1.08-1.26],5.34994534024678e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,19361,1074,1.15 [1.05-1.27],0.0031057324306527
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21566,344,1.18 [1.00-1.39],0.04775268853686
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,21920,698,1.20 [1.07-1.35],0.0015710929035962
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22789,132,1.19 [0.92-1.55],0.1873039099803078
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18721,434,1.31 [1.13-1.51],0.0003312217311188
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19730,1468,1.17 [1.08-1.27],0.000202053308856
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,21815,138,0.88 [0.69-1.14],0.3453145996819599
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22034,281,0.95 [0.79-1.13],0.5516945529649233
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21794,117,1.44 [1.09-1.90],0.0099166409347045
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21795,118,1.42 [1.08-1.87],0.0131982479681545
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11920,113,1.43 [1.07-1.90],0.0142436127292279
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16863,70,1.23 [0.86-1.76],0.2475525700260735
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,16961,168,1.02 [0.81-1.29],0.854940151798822
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8952,139,1.39 [1.07-1.80],0.0127210041669966
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9497,684,1.33 [1.18-1.51],6.5965544548498746e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,16884,91,1.12 [0.82-1.54],0.4657852457652525
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16914,121,1.30 [0.99-1.70],0.0633650055369755
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21329,291,1.26 [1.06-1.50],0.0102520160095725
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",21676,195,1.83 [1.48-2.26],2.3060674518687e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",21711,175,1.79 [1.43-2.24],3.244387861339543e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",21819,156,1.78 [1.41-2.26],1.745279232130444e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21331,104,1.24 [0.92-1.66],0.1537596390877969
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21397,170,1.52 [1.21-1.91],0.0003451206599228
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21252,165,1.01 [0.80-1.28],0.904654247165025
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21230,143,0.99 [0.77-1.28],0.9573568572490008
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22678,137,0.97 [0.75-1.25],0.8241766542315303
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,21591,504,1.05 [0.92-1.21],0.4507095733736722
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,21269,118,1.31 [0.99-1.73],0.055659137273242
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,16883,2134,1.17 [1.09-1.26],1.3356970783716298e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22791,76,1.49 [1.06-2.09],0.0217761161812458
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20408,263,1.43 [1.19-1.72],0.0001514342938225
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20379,234,1.40 [1.15-1.71],0.0007451372938034
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,21685,283,1.18 [0.99-1.41],0.0721225250732714
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,21676,274,1.19 [0.99-1.43],0.0570604098277388
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22227,544,0.94 [0.83-1.07],0.365199938850926
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,21774,91,1.05 [0.77-1.44],0.7560420160879551
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,21821,138,0.83 [0.65-1.07],0.1561157571307204
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22027,344,0.94 [0.80-1.10],0.441106811681953
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,21815,132,0.86 [0.66-1.11],0.2478746394488752
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7263,74,1.23 [0.86-1.76],0.2505594947256228
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19860,1120,1.23 [1.12-1.34],1.805905402508068e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,21299,240,1.16 [0.96-1.42],0.1310846524574568
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21352,293,1.13 [0.94-1.35],0.1944525563977701
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21352,293,1.13 [0.94-1.35],0.1944525563977701
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21266,849,1.19 [1.07-1.32],0.0010157635753178
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Asthma,14887,849,1.23 [1.11-1.37],0.0001166460798557
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14496,849,1.24 [1.11-1.38],9.44961256873072e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14877,839,1.24 [1.11-1.38],8.694149723096846e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22390,122,1.49 [1.14-1.95],0.00330424227823
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21321,94,1.75 [1.29-2.36],0.0002950422414698
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22486,94,1.73 [1.28-2.34],0.0003939227008558
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21315,88,1.65 [1.21-2.25],0.0017354278763414
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,20149,144,1.31 [1.02-1.68],0.0346446662982118
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,20300,295,1.28 [1.07-1.52],0.0063699196672619
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21265,135,1.35 [1.04-1.74],0.0238002065935913
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14798,6398,1.05 [0.99-1.10],0.0854619531486009
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22506,338,0.97 [0.83-1.15],0.7540646801300591
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22949,42,1.00 [0.63-1.58],0.986141591094813
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,22951,38,0.86 [0.53-1.40],0.5462308237160811
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,22258,90,1.12 [0.82-1.53],0.4912659405183344
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22260,92,0.79 [0.58-1.08],0.1458821343290962
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22946,46,1.19 [0.76-1.85],0.4397378816038541
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22267,99,1.03 [0.76-1.39],0.872617350640735
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21996,91,0.82 [0.60-1.12],0.2069554495968727
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22843,59,0.72 [0.50-1.06],0.095526454736293
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16200,340,1.28 [1.08-1.51],0.0034930287864983
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18414,2554,1.09 [1.03-1.17],0.0062006346016784
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,16262,402,0.97 [0.83-1.13],0.709394608455823
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16694,834,1.06 [0.95-1.17],0.3222941607459584
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15946,86,1.42 [1.03-1.97],0.0342526124483477
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16138,278,1.15 [0.96-1.38],0.1400151491512321
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15940,80,0.77 [0.55-1.08],0.1352467506394634
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,16063,203,1.22 [0.99-1.51],0.0674959376283249
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16003,143,1.34 [1.04-1.72],0.0224898990203314
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22773,97,1.46 [1.08-1.97],0.0133524033968318
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,16007,147,1.30 [1.02-1.67],0.0360395554741751
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16836,976,1.12 [1.01-1.24],0.0257345875986131
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,22819,91,0.85 [0.62-1.15],0.288638331464889
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16344,484,1.01 [0.88-1.16],0.8898186007610869
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16082,222,1.14 [0.93-1.40],0.2003810234748313
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22823,120,1.10 [0.84-1.45],0.4839484366904919
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,22806,78,0.78 [0.56-1.08],0.1359402027102976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,19354,2042,0.98 [0.91-1.05],0.4851003601940634
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,18094,782,0.88 [0.79-0.98],0.0235792064238784
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,17447,135,0.78 [0.60-1.01],0.0577760184470158
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,17419,107,1.10 [0.82-1.46],0.5330396535466653
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18424,1112,1.07 [0.97-1.17],0.1654321935120118
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21890,763,1.12 [1.00-1.25],0.0466448259790979
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,16777,2306,1.14 [1.07-1.23],9.537143972729928e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22600,46,1.13 [0.72-1.76],0.6030443703910826
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",22888,60,1.07 [0.72-1.57],0.7493711858012764
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,21187,60,1.08 [0.73-1.59],0.7136802425017429
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21172,45,1.30 [0.83-2.04],0.2523168485609519
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",22810,142,1.08 [0.84-1.40],0.5289125083373792
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21269,142,1.09 [0.85-1.41],0.4945820504344276
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21260,133,0.99 [0.76-1.29],0.9390310324982362
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21757,630,1.10 [0.98-1.25],0.1079505656027013
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21748,621,1.11 [0.99-1.26],0.0852992050122306
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14601,130,0.96 [0.74-1.26],0.7856427176583927
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal stricture,22362,130,0.96 [0.74-1.25],0.7715744319873835
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14555,84,0.91 [0.65-1.27],0.5781165139292556
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15366,895,1.10 [0.99-1.22],0.0765013709633137
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14625,154,1.17 [0.91-1.49],0.2233425095734815
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14791,320,1.47 [1.24-1.74],8.787839463632865e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,20858,287,1.39 [1.16-1.66],0.0002689215400596
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22464,96,1.07 [0.79-1.45],0.6652651695655452
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14576,105,1.02 [0.76-1.38],0.8708466806755741
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14526,55,0.86 [0.57-1.30],0.4759353624093322
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15425,954,1.12 [1.01-1.24],0.0254407422264076
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14832,361,1.05 [0.89-1.23],0.5521554598756122
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22448,80,1.14 [0.82-1.60],0.4319579049432331
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,22063,124,1.10 [0.84-1.44],0.4909291509711895
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,22010,71,0.98 [0.69-1.40],0.9214593488726284
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21457,715,1.26 [1.12-1.41],9.164958485719748e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,21323,581,1.24 [1.09-1.40],0.0009272309199696
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,20862,120,1.10 [0.84-1.45],0.4895747213850543
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20799,57,1.85 [1.25-2.75],0.0021491644739005
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,20815,73,1.45 [1.02-2.06],0.0373629256607996
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),22762,73,1.43 [1.01-2.03],0.0424680839848278
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21448,343,1.36 [1.16-1.60],0.0002062964402084
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21181,76,1.79 [1.26-2.53],0.0010222025789538
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,21170,65,1.90 [1.31-2.75],0.0007746720550087
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21163,58,1.12 [0.75-1.66],0.5886988748045932
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21318,213,1.24 [1.01-1.52],0.0442735175358194
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,21309,204,1.25 [1.01-1.54],0.0407640736740355
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19265,1606,1.10 [1.01-1.19],0.0207763345796181
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22421,106,1.02 [0.76-1.37],0.878898524948663
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22542,438,0.93 [0.80-1.07],0.3116681316889605
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,20872,616,1.22 [1.08-1.38],0.0013117913509525
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,21912,391,1.20 [1.03-1.40],0.0203191597366063
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21590,69,0.74 [0.52-1.07],0.1067678412593111
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,21803,282,1.38 [1.15-1.65],0.0004493652591542
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22640,97,1.12 [0.83-1.51],0.4661221027416617
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22614,71,0.95 [0.67-1.36],0.7902723471896032
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22601,58,0.80 [0.54-1.17],0.2492635102519443
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22521,78,1.01 [0.72-1.42],0.9556328763219036
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22519,76,1.02 [0.72-1.44],0.9119821539991976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22153,49,1.40 [0.92-2.13],0.1213685970424078
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22472,368,0.90 [0.77-1.05],0.1678622788493102
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20370,114,1.08 [0.82-1.44],0.5775770754436139
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20358,102,1.16 [0.86-1.56],0.3399820119539121
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20326,70,1.04 [0.73-1.50],0.8146470012633241
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20478,222,1.09 [0.89-1.33],0.4107346873149707
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20462,206,1.07 [0.86-1.32],0.5526986579419264
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14992,4397,1.10 [1.04-1.16],0.0007756478869663
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16574,2740,1.06 [0.99-1.13],0.083011642835276
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20353,1298,1.03 [0.95-1.13],0.460183619802292
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14018,184,1.62 [1.30-2.03],2.01272756595723e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14421,587,1.20 [1.05-1.36],0.0062854291292384
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22437,178,1.57 [1.26-1.97],6.985519575477947e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22442,162,1.65 [1.31-2.09],2.3906285937585463e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15452,1618,1.03 [0.95-1.12],0.46610596644166
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17966,1618,1.03 [0.95-1.12],0.4502814408416422
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,13924,90,0.84 [0.61-1.15],0.2749986749781054
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22190,88,0.85 [0.62-1.16],0.3063461994032419
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14128,294,1.10 [0.92-1.31],0.3076799802259335
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,13950,116,1.12 [0.84-1.49],0.4345579007893939
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14268,434,1.09 [0.94-1.27],0.2559520881476714
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22732,215,1.06 [0.86-1.30],0.5846417766619363
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14552,718,0.98 [0.87-1.10],0.755399890440568
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14398,564,1.14 [1.00-1.30],0.0531383077917572
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15159,1325,1.01 [0.93-1.11],0.7750026630556658
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13926,92,1.22 [0.89-1.68],0.214150841203921
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14131,297,1.07 [0.89-1.28],0.4636190988246367
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13911,77,0.92 [0.65-1.30],0.6334792684179658
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13923,89,0.96 [0.70-1.32],0.7903755005140072
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14270,436,0.88 [0.76-1.02],0.0978242794418767
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14227,393,0.91 [0.78-1.06],0.20710391985284
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17256,278,1.20 [1.00-1.43],0.0520045841634386
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22227,104,1.85 [1.39-2.47],2.5153173209686416e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22192,69,1.41 [0.98-2.01],0.0627878131896581
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,18982,75,1.39 [0.98-1.96],0.0639243944127169
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19273,366,1.21 [1.03-1.41],0.0197782526616793
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19845,938,1.07 [0.97-1.19],0.1661263154817709
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19148,241,1.26 [1.04-1.53],0.018119015227289
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19020,113,1.27 [0.96-1.68],0.0968382407066265
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19597,690,1.03 [0.92-1.16],0.6300964149704114
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18950,43,0.78 [0.49-1.24],0.3002563405149241
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19120,213,0.98 [0.79-1.20],0.8306445237070521
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18993,86,0.91 [0.66-1.26],0.5624385756489572
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18991,84,0.91 [0.65-1.26],0.5537590562597632
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19038,131,0.89 [0.69-1.16],0.3994197001382942
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18966,59,0.86 [0.58-1.26],0.4293952091995984
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19190,283,1.15 [0.96-1.37],0.1386296721161708
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19389,334,1.12 [0.95-1.32],0.174471057076226
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19136,81,1.18 [0.85-1.64],0.3315016279091085
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19175,120,1.50 [1.14-1.96],0.0038614696057514
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19141,86,0.71 [0.52-0.98],0.0349529988844949
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19096,41,0.78 [0.49-1.25],0.3049299193418799
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19220,165,0.79 [0.63-1.00],0.0513892901842815
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19209,154,0.78 [0.62-1.00],0.0498316328241877
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19351,296,0.98 [0.82-1.16],0.7891755441173838
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19114,59,1.35 [0.91-1.98],0.1322250259322129
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19154,99,0.91 [0.67-1.23],0.5311542709465864
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19195,140,0.85 [0.66-1.09],0.1972620495799515
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19104,49,1.37 [0.89-2.11],0.1468529929931433
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19512,457,1.15 [1.00-1.32],0.0573658112794184
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19245,190,0.98 [0.79-1.22],0.8718198190393212
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19308,253,1.17 [0.97-1.42],0.0980384608363034
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20561,241,1.38 [1.14-1.68],0.0011176759827244
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20755,435,1.24 [1.07-1.44],0.0036043939656798
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20361,41,1.53 [0.96-2.43],0.0753197079519154
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20367,47,1.07 [0.69-1.66],0.7709843474407785
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20407,87,1.04 [0.75-1.43],0.8294873862795548
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16709,4052,1.16 [1.10-1.23],4.39592400346841e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8819,852,1.16 [1.04-1.30],0.0086771870440618
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19241,292,1.43 [1.20-1.71],7.05463757122462e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19030,81,0.93 [0.66-1.30],0.668251954376055
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19293,64,1.78 [1.22-2.58],0.0024572271770326
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19317,88,2.37 [1.74-3.23],5.211845429926345e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19306,77,1.73 [1.23-2.42],0.0015195994116995
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22583,249,0.85 [0.71-1.03],0.1021824666121824
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22350,85,1.78 [1.30-2.46],0.0003970014668586
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22519,185,0.81 [0.65-1.01],0.0608098541474926
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22409,75,1.07 [0.76-1.51],0.705883218791117
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,20031,1202,1.09 [1.00-1.19],0.0596767550958188
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,18940,111,1.24 [0.93-1.65],0.1374930029020632
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18926,97,1.21 [0.90-1.64],0.2119611566794098
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19197,368,1.07 [0.91-1.25],0.4288468023791665
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18969,140,1.02 [0.79-1.31],0.9003841268685975
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19561,732,1.13 [1.01-1.26],0.0335013149062936
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8455,488,1.14 [0.98-1.32],0.0840677929930761
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8037,70,1.07 [0.74-1.56],0.7165625884579578
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8030,63,1.46 [0.99-2.15],0.0561011263176584
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8035,68,1.29 [0.88-1.87],0.1876293084198499
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8061,94,1.38 [1.00-1.89],0.0478013224965585
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8078,111,1.04 [0.77-1.40],0.7893823971199364
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11886,223,1.04 [0.85-1.27],0.6861356019716922
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11738,75,1.24 [0.88-1.75],0.2164665604594927
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11742,79,1.12 [0.80-1.57],0.4926773668443112
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11718,55,0.83 [0.56-1.22],0.3442931010395034
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11862,161,0.89 [0.71-1.13],0.3395046419226072
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11750,49,0.97 [0.63-1.47],0.8786242047240453
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11756,55,0.81 [0.55-1.19],0.2804771847458671
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10994,1803,1.00 [0.93-1.08],0.9173744760291964
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9255,64,0.73 [0.52-1.04],0.0809657091280951
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9242,51,0.77 [0.52-1.14],0.1930070486681405
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9677,486,0.96 [0.84-1.11],0.6014265436204951
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9296,105,0.87 [0.65-1.16],0.3375017653715735
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9667,476,0.95 [0.83-1.10],0.5118443951410101
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9340,149,0.95 [0.74-1.20],0.6497468775648134
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9413,222,1.03 [0.84-1.26],0.78689638157201
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9207,16,0.96 [0.46-1.99],0.9070107966807384
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9237,46,1.17 [0.76-1.81],0.4649393201357895
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",12012,62,1.14 [0.78-1.66],0.4914950440244399
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,12014,57,1.08 [0.73-1.59],0.7029652766715995
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,12020,29,0.96 [0.55-1.66],0.8798325067520325
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",12018,33,1.09 [0.65-1.83],0.7372336670483515
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9263,72,0.81 [0.57-1.14],0.2221435698079659
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9245,54,0.97 [0.65-1.44],0.8611800884597045
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9258,67,1.09 [0.76-1.56],0.6468103720701686
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,12019,87,0.87 [0.63-1.18],0.3687214821997178
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9384,193,0.97 [0.78-1.20],0.7507670931288438
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9280,89,1.06 [0.77-1.45],0.7293080271870458
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",12020,39,1.09 [0.68-1.76],0.7221140876595353
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9301,110,1.32 [0.99-1.76],0.054818185846688
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9239,48,0.96 [0.63-1.48],0.8691594054208569
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9817,626,1.12 [0.99-1.26],0.0807312763486338
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22407,85,1.42 [1.03-1.96],0.0307956314399622
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19542,657,1.17 [1.04-1.32],0.0094034743996431
